BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 10707771)

  • 1. Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms.
    Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J
    Ann Oncol; 2000; 11 Suppl 1():3-10. PubMed ID: 10707771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997.
    Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J; Lister TA; Bloomfield CD
    Ann Oncol; 1999 Dec; 10(12):1419-32. PubMed ID: 10643532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.
    Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J; Lister TA; Bloomfield CD
    Histopathology; 2000 Jan; 36(1):69-86. PubMed ID: 10632755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997.
    Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J; Lister TA; Bloomfield CD
    Hematol J; 2000; 1(1):53-66. PubMed ID: 11920170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.
    Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J; Lister TA; Bloomfield CD
    Mod Pathol; 2000 Feb; 13(2):193-207. PubMed ID: 10697278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.
    Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J; Lister TA; Bloomfield CD
    J Clin Oncol; 1999 Dec; 17(12):3835-49. PubMed ID: 10577857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report.
    Jaffe ES; Harris NL; Diebold J; Muller-Hermelink HK
    Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S8-12. PubMed ID: 9894466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
    Meusers P; Brittinger G
    Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A practical approach to the pathology of lymphoid neoplasms: a revised European-American classification from the International Lymphoma Study Group.
    Harris NL
    Important Adv Oncol; 1995; ():111-40. PubMed ID: 7672801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous lymphomas: a proposal for a unified approach to classification using the R.E.A.L./WHO Classification.
    Jaffe ES; Sander CA; Flaig MJ
    Ann Oncol; 2000; 11 Suppl 1():17-21. PubMed ID: 10707773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The problem of classifying lymphomas: an orderly prescription for progress.
    Berard CW; Hutchison RE
    Ann Oncol; 1997; 8 Suppl 2():3-9. PubMed ID: 9209632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. World Health Organization Classification of lymphomas: a work in progress.
    Jaffe ES; Harris NL; Diebold J; Müller-Hermelink HK
    Ann Oncol; 1998; 9 Suppl 5():S25-30. PubMed ID: 9926234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of malignant lymphoma.
    Uppenkamp M; Feller AC
    Onkologie; 2002 Dec; 25(6):563-70. PubMed ID: 12566903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Malignant lymphoma: REAL classification to new WHO classification].
    Kikuchi M
    Nihon Rinsho; 2000 Mar; 58(3):578-85. PubMed ID: 10741128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New REAL clinical entities.
    Fisher RI; Miller TP; Grogan TM
    Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S5-12. PubMed ID: 9672769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Who is WHO and what was REAL?
    Cogliatti SB; Schmid U
    Swiss Med Wkly; 2002 Dec; 132(43-44):607-17. PubMed ID: 12587044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Worldwide consensus: the way from the KIEL classification to the REAL classification to the WHO classification].
    Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 1999; 83():155-61. PubMed ID: 10714206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Principles of the revised European-American Lymphoma Classification (from the International Lymphoma Study Group).
    Harris NL
    Ann Oncol; 1997; 8 Suppl 2():11-6. PubMed ID: 9209633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The classification of lymphomas and leukemias.
    Ottensmeier C
    Chem Biol Interact; 2001 Jun; 135-136():653-64. PubMed ID: 11397419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new WHO nomenclature: lymphoid neoplasms.
    Leclair SJ; Rodak BF
    Clin Lab Sci; 2002; 15(1):55-9. PubMed ID: 12778957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.